The purpose of this study is to determine if zigakibart is safe and effective for long-term use in patients with immunoglobulin A nephropathy (IgAN). This is a…

Kidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more

~Estimated

~$10 – $8,750

Novartis PharmaceuticalsNCT06858319

Phase 2

A Multicenter, Single Arm, Open Label Biopsy Study to Evaluate Structural and Functional Changes in Kidneys of Adult Patients With IgA Nephropathy Receiving Iptacopan on Top of Supportive Care

A study to investigate the impact of iptacopan treatment on the underlying immunopathology in patients with IgAN by assessing changes in key clinical and molec…

Glomerulonephritis, IGAImmunoglobulin A Nephropathy

~Estimated

~$10 – $8,750

Novartis PharmaceuticalsNCT06797518

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subj…

Kidney DiseasesKidney Failure, ChronicDiabetic Nephropathy+2 more

~Estimated

~$10 – $1,125

The Rogosin InstituteNCT01802034